Ronald Kirk Huntsman serves as Executive at Vivos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ronald Kirk Huntsman has executed 12 insider transactions totaling $116.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 20, 2023 involved purchasing 14,000 shares valued at $7.4K.
Ronald Kirk Huntsman currently holds 86,521 shares of Vivos Therapeutics, Inc. (VVOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Kirk Huntsman has been a net buyer of VVOS stock. They have purchased $116.3K and sold $0 worth of shares.
Ronald Kirk Huntsman's most recent insider trade was on Jun 20, 2023, when they purchased 14,000 shares at $0.53 per share.
Get notified when new Form 4 filings are submitted
| $0.54 |
| Discretionary |
| Jun 16, 2023 | VVOS | $2.6K | Purchase | 5,000 | $0.53 | Discretionary |
| Jun 15, 2023 | VVOS | $11 | Purchase | 21 | $0.50 | Discretionary |
| Jun 14, 2023 | VVOS | $4.9K | Purchase | 10,000 | $0.49 | Discretionary |
| Dec 23, 2022 | VVOS | $10.0K | Purchase | 20,000 | $0.50 | Discretionary |
| Jun 1, 2022 | VVOS | $7.3K | Purchase | 4,000 | $1.83 | Discretionary |
| May 31, 2022 | VVOS | $16.2K | Purchase | 8,000 | $2.03 | Discretionary |
| Sep 21, 2021 | VVOS | $21.6K | Purchase | 5,000 | $4.31 | Discretionary |
| Aug 17, 2021 | VVOS | $15.0K | Purchase | 5,000 | $3.00 | Discretionary |
| May 25, 2021 | VVOS | $21.5K | Purchase | 4,000 | $5.38 | Discretionary |
| Dec 11, 2020 | VVOS | $4.3K | Purchase | 500 | $8.50 | Discretionary |